A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia
Clinical trial NCT07680829 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680829
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-06-01
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.